K. A. WATANABE

1.4k total citations
47 papers, 1.1k citations indexed

About

K. A. WATANABE is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, K. A. WATANABE has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Organic Chemistry, 28 papers in Molecular Biology and 10 papers in Infectious Diseases. Recurrent topics in K. A. WATANABE's work include Carbohydrate Chemistry and Synthesis (14 papers), Synthesis and Characterization of Heterocyclic Compounds (13 papers) and Biochemical and Molecular Research (13 papers). K. A. WATANABE is often cited by papers focused on Carbohydrate Chemistry and Synthesis (14 papers), Synthesis and Characterization of Heterocyclic Compounds (13 papers) and Biochemical and Molecular Research (13 papers). K. A. WATANABE collaborates with scholars based in United States, Japan and Canada. K. A. WATANABE's co-authors include Jack J. Fox, André A. Pavia, J. C. Martin, René Lemieux, R. U. Lemieux, Ying‐Chih Cheng, Ginger E. Dutschman, H. Machida, C. K. CHU and Iris Wempen and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

K. A. WATANABE

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. A. WATANABE United States 17 575 499 180 178 99 47 1.1k
Christiane Yoakim Canada 28 624 1.1× 1.1k 2.1× 306 1.7× 201 1.1× 40 0.4× 51 1.8k
Patricia A. Benkovic United States 25 1.3k 2.3× 575 1.2× 159 0.9× 69 0.4× 99 1.0× 43 2.0k
Stephen F. Brady United States 17 756 1.3× 449 0.9× 194 1.1× 111 0.6× 136 1.4× 26 1.2k
Stanley A. Lang United States 18 362 0.6× 577 1.2× 118 0.7× 169 0.9× 88 0.9× 52 1.2k
J.‐L. IMBACH France 20 663 1.2× 530 1.1× 304 1.7× 92 0.5× 33 0.3× 69 1.2k
James M. Riordan United States 14 475 0.8× 464 0.9× 178 1.0× 74 0.4× 54 0.5× 48 859
Soo S. Ko United States 20 561 1.0× 841 1.7× 169 0.9× 80 0.4× 43 0.4× 32 1.5k
Krystyna Lesiak United States 23 865 1.5× 304 0.6× 315 1.8× 179 1.0× 20 0.2× 67 1.3k
T. L. NAGABHUSHAN United States 19 635 1.1× 489 1.0× 41 0.2× 45 0.3× 94 0.9× 33 1.2k
Dominik Wernic Canada 16 1.1k 1.8× 314 0.6× 187 1.0× 208 1.2× 124 1.3× 26 1.6k

Countries citing papers authored by K. A. WATANABE

Since Specialization
Citations

This map shows the geographic impact of K. A. WATANABE's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. A. WATANABE with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. A. WATANABE more than expected).

Fields of papers citing papers by K. A. WATANABE

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. A. WATANABE. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. A. WATANABE. The network helps show where K. A. WATANABE may publish in the future.

Co-authorship network of co-authors of K. A. WATANABE

This figure shows the co-authorship network connecting the top 25 collaborators of K. A. WATANABE. A scholar is included among the top collaborators of K. A. WATANABE based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. A. WATANABE. K. A. WATANABE is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alauddin, Mian M., Peter S. Conti, John D. Fissekis, & K. A. WATANABE. (2002). SYNTHESIS OF 2′-DEOXY-2′-FLUORO- 1-β-d-ARABINOFURANOSYL URACIL DERIVATIVES: A METHOD SUITABLE FOR PREPARATION OF [18F]-LABELED NUCLEOSIDES. Synthetic Communications. 32(11). 1757–1764. 9 indexed citations
2.
3.
4.
Sonenberg, Martin, Ting‐Li Su, K. A. WATANABE, et al.. (1988). Anti-fertility and other actions of gossypol analogues. Contraception. 37(3). 247–255. 17 indexed citations
5.
Chou, Ting‐Chao, et al.. (1987). Synthesis and biological effects of 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil. Antimicrobial Agents and Chemotherapy. 31(9). 1355–1358. 32 indexed citations
6.
Perlman, Michael E., K. A. WATANABE, Raymond F. Schinazi, & Jack J. Fox. (1985). ChemInform Abstract: NUCLEOSIDES. 133. SYNTHESIS OF 5‐ALKENYL‐1‐(2‐DEOXY‐2‐FLUORO‐β‐D‐ARABINOFURANOSYL)CYTOSINES AND RELATED PYRIMIDINE NUCLEOSIDES AS POTENTIAL ANTIVIRAL AGENTS. Chemischer Informationsdienst. 16(44). 2 indexed citations
7.
Haspel, Howard C., Yan Ren, K. A. WATANABE, Martin Sonenberg, & Robert E. Corin. (1984). Cytocidal effect of gossypol on cultured murine erythroleukemia cells is prevented by serum protein.. Journal of Pharmacology and Experimental Therapeutics. 229(1). 218–225. 39 indexed citations
8.
Chou, Ting‐Chao, C. López, Joseph M. Colacino, et al.. (1984). Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.. Molecular Pharmacology. 26(3). 587–593. 7 indexed citations
9.
Feinberg, Aaron, Jack J. Fox, K. A. WATANABE, et al.. (1984). Structures of metabolites isolated from urine of mice treated with the antiviral agent, 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-methyluracil.. Drug Metabolism and Disposition. 12(6). 784–786. 3 indexed citations
10.
Cheng, Ying‐Chih, Ginger E. Dutschman, Jack J. Fox, K. A. WATANABE, & H. Machida. (1981). Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases. Antimicrobial Agents and Chemotherapy. 20(3). 420–423. 110 indexed citations
11.
WATANABE, K. A., et al.. (1981). Nucleosides. 114. 5'-O-Glucuronides of 5-fluorouridine and 5-fluorocytidine. Masked precursors of anticancer nucleosides. Journal of Medicinal Chemistry. 24(7). 893–897. 28 indexed citations
12.
CHU, C. K., U. REICHMAN, K. A. WATANABE, & Jack J. Fox. (1977). Nucleosides. 104. Synthesis of 4-amino-5-(D-ribofuranosyl)pyrimidine C-nucleosides from 2-(2,3-O-isopropylidene-5-O-trityl-D-ribofuranosyl)acetonitrile. The Journal of Organic Chemistry. 42(4). 711–714. 20 indexed citations
13.
WATANABE, K. A., et al.. (1976). Nucleosides—XCV. Tetrahedron. 32(13). 1493–1495. 2 indexed citations
14.
Burchenal, Joseph H., Kathleen Kalaher, Tara O’Toole, et al.. (1976). Antileukemic effects of pseudoisocytidine, a new synthetic pyrimidine C-nucleoside.. PubMed. 36(4). 1520–3. 58 indexed citations
15.
WATANABE, K. A., et al.. (1972). Nucleosides LXXVII. Rotational isomerism of certain 3-β--glucopyranosyl-6-methyluracils. Tetrahedron Letters. 13(37). 3911–3914. 5 indexed citations
16.
Fox, Jack J., Robert S. Klein, Michael P. Kotick, & K. A. WATANABE. (1971). Nucleosides. LXXIII. Ribosyl analogs of chloramphenicol. The Journal of Organic Chemistry. 36(26). 4113–4116. 15 indexed citations
17.
18.
Lemieux, R. U., K. A. WATANABE, & André A. Pavia. (1969). Anomeric deoxy and unsaturated methyl pentofuranosides and pentopyranosides. Canadian Journal of Chemistry. 47(23). 4413–4426. 35 indexed citations
19.
Lemieux, R. U., et al.. (1968). Preparation of unsaturated carbohydrates. A facile synthesis of methyl 4,6-O-Benzylidene-D-hex-2-enopyranosides. Canadian Journal of Chemistry. 46(1). 61–69. 78 indexed citations
20.
FRIEDMAN, H. A., et al.. (1965). Nucleosides XXVIII. 3′‐amino‐3′ ‐deoxyhexopyranosyl nucleosides. Part III. Synthesis of 3′‐amino‐3′‐deoxyhexopyranosyl adenines. Journal of Heterocyclic Chemistry. 2(2). 188–191. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christiane Yoakim Breakdown of academic impact, for papers by Patricia A. Benkovic Breakdown of academic impact, for papers by Stephen F. Brady Breakdown of academic impact, for papers by Stanley A. Lang Breakdown of academic impact, for papers by J.‐L. IMBACH Breakdown of academic impact, for papers by James M. Riordan Breakdown of academic impact, for papers by Soo S. Ko Breakdown of academic impact, for papers by Krystyna Lesiak Breakdown of academic impact, for papers by T. L. NAGABHUSHAN Breakdown of academic impact, for papers by Dominik Wernic
Rankless by CCL
2026